Freund R, Calderone A, Dawe C J, Benjamin T L
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.
J Virol. 1991 Jan;65(1):335-41. doi: 10.1128/JVI.65.1.335-341.1991.
By testing recombinants between "high tumor" (inducing a high incidence of tumors) and "low tumor" (inducing a low incidence of tumors) strains of polyomavirus, we have previously shown that the key determinant(s) for induction of a high tumor profile resides in coding regions of the high tumor strain (R. Freund, G. Mandel, G. G. Carmichael, J. P. Barncastle, C. J. Dawe, and T. L. Benjamin, J. Virol. 61:2232-2239, 1987). Three single-amino-acid differences between the PTA (high tumor) and RA (low tumor) virus strains have now been identified by DNA sequencing, one each in the large T antigen, in the region common to the middle and small T antigens, and in the major capsid protein VP1. Further tests of appropriate recombinants and oligonucleotide-induced mutants show that VP1 of PTA is the major determinant for induction of a high tumor profile, including all tumors of epithelial origin. The differential effect of the VP1s of PTA and RA on the tumor profile is discussed in terms of a likely contribution of the polymorphic region of VP1 to binding of receptors and infection of different cell types in the animal. The polymorphism in the large T antigen has a more restricted action, which is seen only when tested in virus carrying the VP1 type of PTA; the PTA large T antigen then promotes more rapid growth of tumors of salivary gland and thymus than the RA large T antigen.
通过检测多瘤病毒“高肿瘤”(诱导高肿瘤发生率)和“低肿瘤”(诱导低肿瘤发生率)毒株之间的重组体,我们先前已表明,诱导高肿瘤特征的关键决定因素位于高肿瘤毒株的编码区域(R. 弗罗因德、G. 曼德尔、G. G. 卡迈克尔、J. P. 巴恩卡斯尔、C. J. 道、T. L. 本杰明,《病毒学杂志》61:2232 - 2239, 1987)。现已通过DNA测序确定了PTA(高肿瘤)和RA(低肿瘤)病毒毒株之间的三个单氨基酸差异,分别位于大T抗原、中T和小T抗原的共同区域以及主要衣壳蛋白VP1中。对合适的重组体和寡核苷酸诱导突变体的进一步检测表明,PTA的VP1是诱导高肿瘤特征的主要决定因素,包括所有上皮起源的肿瘤。根据VP1的多态性区域对动物中不同细胞类型的受体结合和感染可能的贡献,讨论了PTA和RA的VP1对肿瘤特征的差异影响。大T抗原中的多态性作用更有限,仅在携带PTA型VP1的病毒中检测时才可见;此时PTA大T抗原比RA大T抗原更能促进唾液腺和胸腺肿瘤的快速生长。